Cadila gets US FDA approval for hydroxychloroquine sulfate tabs (PharmaBiz)
Cadila Healthcare Ltd has received an approval from the US FDA for hydroxychloroquine sulfate tablets in the strength of 200 mg. The drug falls in the DMARD (Disease Modifying Anti-Rheumatic Drug) segment and is used in the management of rheumatoid arthritis.

Taro gets US FDA approval for ciclopirox topical solution (PharmaBiz)
Taro Pharmaceutical Industries Ltd. has received approvals from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Ciclopirox topical solution, 8 per cent (nail lacquer) (ciclopirox nail lacquer) and its supplemental ANDA for loratadine Syrup (Oral Suspension), 5 mg/5 mL (loratadine syrup) in a grape flavored formulation, an over-the-counter (OTC) ...